Gema Lorenzo

Valdeolmos, MD 28130, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

The Changing Landscape of Akabane Virus: A Comprehensive Review.

The Changing Landscape of Akabane Virus: A Comprehensive Review.

Journal: Viruses
Published: June 10, 2026

A Single Dose of Live-Attenuated Rift Valley Fever Virus Vector Expressing Peste Des Petits Ruminants Virus (PPRV) H or F Antigens Induces Immunity in Sheep.

A Single Dose of Live-Attenuated Rift Valley Fever Virus Vector Expressing Peste Des Petits Ruminants Virus (PPRV) H or F Antigens Induces Immunity in Sheep.

Journal: Vaccines
Published: September 10, 2025

Generation and characterization of an ovine cell line derived from peripheral blood and its potential use in the study of livestock and zoonotic viral infections.

Generation and characterization of an ovine cell line derived from peripheral blood and its potential use in the study of livestock and zoonotic viral infections.

Journal: Virology journal
Published: June 20, 2025

The 40Fp8 vaccine strain is safe and protects pregnant ewes from a virulent RVFV challenge.

The 40Fp8 vaccine strain is safe and protects pregnant ewes from a virulent RVFV challenge.

Journal: NPJ vaccines
Published: February 07, 2025

Prime-Boost Vaccination Based on Nanospheres and MVA Encoding the Nucleoprotein of Crimean-Congo Hemorrhagic Fever Virus Elicits Broad Immune Responses.

Prime-Boost Vaccination Based on Nanospheres and MVA Encoding the Nucleoprotein of Crimean-Congo Hemorrhagic Fever Virus Elicits Broad Immune Responses.

Journal: Vaccines
Published: December 27, 2024

Novel replication-competent reporter-expressing Rift Valley fever viruses for molecular studies.

Novel replication-competent reporter-expressing Rift Valley fever viruses for molecular studies.

Journal: Journal of virology
Published: December 12, 2024

Nucleotide Resolution Mapping of Rift Valley Fever Virus Nucleoprotein-Genome RNA Interactions.

Nucleotide Resolution Mapping of Rift Valley Fever Virus Nucleoprotein-Genome RNA Interactions.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 22, 2024

Co-expression of VP2, NS1 and NS2-Nt proteins by an MVA viral vector induces complete protection against bluetongue virus.

Co-expression of VP2, NS1 and NS2-Nt proteins by an MVA viral vector induces complete protection against bluetongue virus.

Journal: Frontiers in immunology
Published: May 29, 2024

Engineering recombinant replication-competent bluetongue viruses expressing reporter genes for in vitro and non-invasive in vivo studies.

Engineering recombinant replication-competent bluetongue viruses expressing reporter genes for in vitro and non-invasive in vivo studies.

Journal: Microbiology spectrum
Published: February 14, 2024

Safety and Efficacy upon Infection in Sheep with Rift Valley Fever Virus ZH548-rA2, a Triple Mutant Rescued Virus.

Safety and Efficacy upon Infection in Sheep with Rift Valley Fever Virus ZH548-rA2, a Triple Mutant Rescued Virus.

Journal: Viruses
Published: December 20, 2023

Nucleocapsids of the Rift Valley fever virus ambisense S segment contain an exposed RNA element in the center that overlaps with the intergenic region.

Nucleocapsids of the Rift Valley fever virus ambisense S segment contain an exposed RNA element in the center that overlaps with the intergenic region.

Journal: Nature communications
Published: October 16, 2023

Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models.

Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models.

Journal: Vaccines
Published: April 14, 2023
Showing 1-12 of 32

Last Updated: 09/26/2026